Ethanaminium, 2-hydroxy-N-(iodomethyl)-N,N-dimethyl-, iodide (1:1), 97%, 100mg

(R)-3-(Boc-amino)-2-oxo-1-pyrrolidine-acetic acid, 99.0%, 250mg

4-Cyano-3-(5,5-Dimethyl-[1,3,2]dioxaborinan-2-yl)-pyridine, 98+%, 1g

N-methyl-1-(3-methyl-1,2,4-oxadiazol-5-yl)methanamine hydrochloride, 95.0%, 2.5g

2-(Bromomethyl)-6-methylpyridine, 97.0%, 5g

(R)-2-Benzylsuccinic acid, 97%, 250mg

Incubation shaker SI-200D, 1 piece

2,6-Difluoropyridine-3-boronic acid, 97.0%, 25g

4-Bromo-4'-chloro-3'-fluorobenzophenone, 97.0%, 1g

Ferrocenyl 1,1'-Bis(thiophene-2-carboxylate)>98.0%(HPLC)(T)500mg

1-([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL)-N-METHYLMETHANAMINE HCL, 95.0%, 1g

6-METHYL-7-OXABICYCLO[4.1.0]HEPTAN-2-ONE, 95.0%, 5g

Methyl 3-amino-3-[4-(methylsulfanyl)phenyl]propanoate hydrochloride, 95%, 250mg